TrialClinical immunology (Orlando, Fla.)2018

Phase Ib trial of folate binding protein (FBP)-derived peptide vaccines, E39 and an attenuated version, E39': An analysis of safety and immune response.

Timothy J Vreeland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.